Big Pharma aren't looking at molecules that target protein vpu yet...
So I think Biotron could be leading the race there.
Bitoron have thought of BIT225 as a late-acting drug, but form the above article it appears Vpu inhibitors might play a more primary role in he initial stage of an HIV infection.
achilles heel, page-4
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
